Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03687437
Other study ID # Mai Zakaria
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 30, 2018
Est. completion date March 1, 2019

Study information

Verified date July 2019
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

70 patients with suspicious oral lichen planus; atrophic and bullous erosive forms will be included. The blood samples will be drawn between 08:00 and 09:00 AM, after a fasting period of 12 hours, and analysis were performed within 2 hours of the sampling. The MPV and other hematologic parameters will be measured in a blood sample. A surgical biopsy will be performed for histopathological assessment.


Description:

70 patients with suspicious oral lichen planus; atrophic and bullous erosive forms will be included for conventional clinical examination under incandescent projected light. Using biopsy as a gold standard, all patients will be biopsied.

Blood Samples For all participants, the blood samples will be drawn between 08:00 and 09:00 AM, after a fasting period of 12 hours, and analysis were performed within 2 hours of the sampling. The MPV and other hematologic parameters will be measured in a blood sample that will be collected in tubes containing EDTA. Complete blood cell analysis will be performed in hematology laboratory, New Kasr Al-Aini Teaching Hospital, Faculty of Medicine, Cairo University. For reliable MPV measurement, the investigator will standardize the time delay between sampling and analysis to <2 hours for all patients.

Biopsy preparation A surgical biopsy will be performed for histopathological assessment. All clinically identified lesions underwent biopsies where specimens will be placed in 10% buffered formalin for fixation. Paraffin embedded material will be cut into 4 μm thick sections and will be stained with haematoxylin + eosin then submitted for histopathological evaluation by a senior oral pathologist blinded to the clinical findings.

Statistical analysis

The collected data will be entered through the SPSS version 18.0 software. Sensitivity, Specificity, Positive Predictive Value (PPV), Negative Predictive Value (NPV) and Accuracy were calculated for MPV. The results will be compared with histopathological results using Chi-Square test with p value set as < 0.05.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date March 1, 2019
Est. primary completion date February 1, 2019
Accepts healthy volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Inclusion criteria is suspected oral lichen planus, age 18-60

Exclusion Criteria:

- Foreseeable missing opportunity of follow-up examination, Pregnancy, heart-, pulmonary, liver- and kidney disease, chronic pain syndrome nursing, drug addiction, recent operations, and diseases like heart, metabolism, CNS, infectious, circulation, systemic, malignant and immune system affecting diseases as well as blood coagulation disorders and allergic reactions to pharmaceuticals and antibiotics

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Blood sample
Complete blood count

Locations

Country Name City State
Egypt Oral Medicine and Periodontology Department Cairo
Egypt Faculty of Dentistry, Cairo University Giza

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

References & Publications (1)

Gupta S, Ghosh S, Gupta S. Interventions for the management of oral lichen planus: a review of the conventional and novel therapies. Oral Dis. 2017 Nov;23(8):1029-1042. doi: 10.1111/odi.12634. Epub 2017 Mar 3. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Complete blood count blood sample between 08:00 and 09:00 AM and analysis to <2 hours for all patients Once at the time of the first visit
See also
  Status Clinical Trial Phase
Recruiting NCT03320460 - Photobiomodulation in Oral Lichen Planus N/A
Completed NCT02276573 - Study of Inflammatory Role of Epstein-Barr Virus (EBV) in Atrophic and Erosive Forms of Oral Lichen Planus N/A
Recruiting NCT06158113 - Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study Phase 2
Completed NCT00130572 - Efficacy of Elidel Cream on Erosive Oral Lichen Planus Phase 3
Completed NCT04673916 - Treatment Protocols for Patients With Symptomatic Oral Lichen Planus N/A
Not yet recruiting NCT06362005 - The Efficacy of Selenium as an Alternative or Complementary Topical Treatment of Oral Lichen Planus Phase 4
Completed NCT00133107 - Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus N/A
Completed NCT00102557 - Hydroxychloroquine vs. Clobetasol Rinse to Treat Oral Lichen Planus Phase 2
Completed NCT04718311 - Study on Treatment for Patients With Symptomatic Oral Lichen Planus N/A
Recruiting NCT05330572 - Clinical and Molecular Correlates of Response to First Line Treatment in Lichen Planus
Completed NCT00656214 - Treatmant of Oral Lichen Planus With Lycopene Phase 2
Completed NCT04976673 - Comparison of Clinical Efficiency of Photodynamic Therapy and Topical Corticosteroid in Treatment of Oral Lichen Planus Phase 2
Completed NCT00746772 - Efficacy of Purslane in Treatment of Oral Lichen Planus Phase 2